Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients' Outcome; a Cross-sectional Study

Introduction Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydr...

Full description

Saved in:
Bibliographic Details
Published in:Archives of academic emergency medicine 2022-01, Vol.10 (1), p.e63-e63
Main Authors: Alizadeh, Nafiseh, Tabatabaei, Fatemeh-Sadat, Azimi, Amirali, Faraji, Neda, Akbarpour, Samaneh, Dianatkhah, Mehrnoush, Moghaddas, Azadeh
Format: Article
Language:English
Subjects:
COVID-19
Emergency Service, Hospital
L-Lactate Dehydrogenase
Original
Prognosis
Serum Albumin
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes. MethodsThis retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction of mortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR
ISSN:2645-4904
DOI:10.22037/aaem.v10i1.1646